动物疼痛管理的全球市场 (2022-2028年):各药物类型、动物类型、终端用户、给药途径、流通管道的规模、占有率、成长分析、预测

Global Veterinary Pain Management Market Size, Share, Growth Analysis, By Drug Type, By Animal Type, By End Users, By Route of Administration, By Distribution Channel - Industry Forecast 2022-2028

出版日期: 2022年11月13日 | 出版商:

SkyQuest | 英文 272 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球动物疼痛管理的市场规模，从2021年的13亿5,000万美元，在预测期间中预计以7％的年复合成长率发展，2028年成长到21亿5,000万美元的规模。

宠物的疾病盛行率的上升促进该市场的成长。根据Animal Cancer Foundation，2018年在美国有6,000万头以上的狗和3,000万头以上的猫诊断出末期癌症。兽医数增加，已开发国家的兽医工资水准的上升，低成本治疗的需求高涨，动物的健康和福利相关意识的高涨等要素也促进在预测期间内的市场成长。

本报告提供全球动物疼痛管理的市场调查，市场概要，市场的各种影响因素的分析，技术、革新趋势，市场规模的变化、预测，各种区分、各地区的明细，竞争情形，主要企业简介等彙整资讯。

市场概要
市场规模
市场动态
促进因素
机会
阻碍因素
课题
主要市场洞察
技术分析
价格分析
供应链分析
价值链分析
市场生态系统
IP分析
贸易分析
Start-Ups分析
原料分析
革新矩阵
开发中产品分析
宏观经济指标
主要投资分析
主要的成功因素
竞争的程度
市场动态与展望
市场动态
促进因素
机会
阻碍因素
课题
法规情形
波特分析
未来的阻碍相关Skyquest的特别洞察
全球动物疼痛管理市场:各药物类型
市场概要
类鸦片物质
吗啡
Hydromorphone
可待因
α2-肾上腺素促效剂
Xylazine
Medetomidine
局部麻醉剂
Bupivacaine
Lidocaine
Chloropropane
非类固醇系抗发炎药(NSID)
Etodolac
吩坦尼
Meloxicam
镇静剂
皮质类固醇
其他
全球动物疼痛管理市场:各动物类型
市场概要
家畜
宠物
全球动物疼痛管理市场:各终端用户
市场概要
动物医院药局
零售动物药局
线上药局
全球动物疼痛管理市场:各给药途径
市场概要
口服
非口服
全球动物疼痛管理市场:各流通管道
市场概要
动物医院
药局
全球动物疼痛管理市场:各地区
市场概要
北美
欧洲
亚太地区
南美
中东、非洲
竞争情形
主要5家公司的比较
主要企业的市场定位
主要企业的采用策略
主要成功策略
市场上最近的活动
主要企业的市场占有率
主要企业简介
Zoetis
Elanco
Bayer AG
Norbrook
Ceva
Dechra Pharmaceuticals
Assisi Animal Health
Merck Sharp &Dohme Corp
Boehringer Ingelheim International GmbH
Virbac
IDEXX Laboratories
Vetoquinol
Evonik Industries AG
DuPont
DSM
Adisseo
BASF SE
ADM
Nutreco
Novusint
Cargill Incorporated
Charoen Pokphand Group
Sumitomo Chemical
Kemin Industries, Inc.
Medtronic

简介目录

Product Code: SQMIG35I2099

Veterinary Pain Management Market size was valued at USD 1.35 billion in 2021 and is expected to reach USD 2.15 billion by 2028, at a CAGR of 7% during the forecast period (2022-2028).

Veterinary pain management includes diagnostic testing, prevention, and treatment of pain in animals caused by a variety of variables including as vital organ disorders, physical damage, central nervous system and spinal problems, and surgical methods. Practitioners must be able to recognise and relieve pain in a wide range of pet diseases in order to control pain in the veterinary industry. Pain in animals can be caused by a variety of circumstances, including arthritis, cancer, surgical intervention, and so on. Pain can also be connected with aggressive behavior, diminished or complete loss of activity, and other symptoms in animals. Pet and agricultural animal performance can be affected by animal discomfort.

The rising prevalence of pet ailments is driving growth in the Veterinary Pain Management Market. According to the Animal Cancer Foundation, more than 60 million dogs and 30 million cats in the United States were diagnosed with terminal cancer in 2018. The increasing number of veterinary practitioners, as well as rising veterinary practitioner salary levels in developed countries, are two significant drivers driving total expansion. Furthermore, rising demand for low-cost treatment procedures, as well as greater awareness about animal health and welfare, are likely to fuel the growth of the Veterinary Pain Management Market over the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of global Veterinary Pain Management Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Segments covered in this report:

Global veterinary pain management market is segmented based on drug type, animal type, end users, route of administration, distribution channel, region. Based on drug type Veterinary Pain Management Market is segmented into Opioids, Morphine, Hydromorphone, Codeine, α2-adrenergic Agonists, Xylazine, Medetomidine, Local Anaesthetics, Bupivacaine, Lidocaine, Chloropropane, Nonsteroidal Anti-inflammatory Drugs (NSIDs), Etodolac, Fentanyl, Meloxicam, Sedatives, Corticosteroids, Others. Based on animal type Veterinary Pain Management Market is segmented as Livestock animal, Companion animal. Based on end user, the Veterinary Pain Management Market is segmented as Veterinary Hospital pharmacies, Retail Veterinary Pharmacies, Online Pharmacies. Based on route of administration Veterinary Pain Management Market is segmented as Oral Preparations, Parenteral Preparations. Based on distribution channel Veterinary Pain Management Market is segmented as veterinary hospitals, pharmacies. Based on region market is segmented into North America, Asia Pacific, Europe, Latin America and Middle East Africa.

Drivers

Increasing animal welfare funding to drive market growth. The increase in companion animal ownership and big livestock population, the increase in pet insurance with an increase in animal welfare spending, and the increased prevalence of animal diseases are all projected to have an impact on the expansion of the worldwide veterinary pain treatment sector. Furthermore, the rise of the sector is being pushed by an increase in the necessity to preserve animal health and safety in industrialised countries, as well as an increase in global acceptability of pet insurance. Furthermore, the increased prevalence of animal diseases that cause pain and inflammation is moving the sector ahead. Over the projection period, the expanding number of pet owners worldwide is expected to boost industry growth.

Restraint

High R&D expenditures, inadequate infrastructure, uneven distribution of medical services, and a lack of awareness in developing nations are projected to hinder industry expansion. Furthermore, a lack of favourable reimbursement scenarios and technology penetration in developing economies, a decline in advanced-country healthcare expenditures, high costs associated with pet care, and a lack of suitable infrastructure in low- and middle-income countries are expected to pose challenges to the market during the forecast period.

Market Trends

Exploration of undiscovered markets is being expanded in order to offer growth prospects for important companies. In comparison, the growing use of non-traditional and non-pharmaceutical treatment approaches, as well as unexplored new markets, are predicted to provide the industry with future growth potential.